18.84 USD
↗ 0.77 (4.25%)LIVE (AS OF 10:13 AM EDT)
GH Research PLC Ordinary Shares
GHRSNASDAQ • USD
Market: OPEN
GH Research PLC Ordinary Shares (GHRS) trades at $18.84 per share. Technical indicators currently signal "Sell". This is driven by a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Oct 23, 2026.
Open?$18.16
High?$18.90
Low?$17.54
Prev. Close?$18.07
Volume?38.2K
Avg. Volume?N/A
VWAP?$18.54
Bid / Ask
Bid?$15.62 × 100
Ask?$21.09 × 100
Spread?$5.47
Midpoint?$18.36
Valuation & Ratios
Market Cap?1.2B
Shares Out?68.6M
Float?44.1M
Float %?64.3%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?4.00%Low
Short Interest?1.8M
Days to Cover?5.0
Free Float44.1M
Avg Daily Volume352.8K
Settlement Date2026-09-30